Beijing Biohealthcare Biotechnology Co.,Ltd

Quick facts

Phase 2 pipeline

• Gimeracil and Oteracil Porassium Capsules · Oncology
  Inhibits dihydroorotate dehydrogenase

Phase 1 pipeline

• CART20

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Beijing Biohealthcare Biotechnology Co.,Ltd portfolio CI brief
• Beijing Biohealthcare Biotechnology Co.,Ltd pipeline updates RSS

Related

• Sector hub: All tracked pharma companies